title: Efficacy and safety of more intensive lowering of LDL cholesterol.
authors.forename: Stefanos
authors.initials: S
authors.lastname: Bonovas
authors.forename: Georgios
authors.initials: G
authors.lastname: Nikolopoulos
authors.forename: Nikolaos M
authors.initials: NM
authors.lastname: Sitaras
mesh_terms: D000367:Age Factors; D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D015994:Incidence; D015201:Meta-Analysis as Topic; D009369:Neoplasms / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology*; D016017:Odds Ratio; D017035:Pravastatin / Q000008:administration & dosage / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin